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A post-transcriptional mechanism pacing
expression of neural genes with precursor cell
differentiation status
Weijun Dai1, Wencheng Li2, Mainul Hoque2, Zhuyun Li1, Bin Tian2 & Eugene V. Makeyev1,3
Nervous system (NS) development relies on coherent upregulation of extensive sets of genes
in a precise spatiotemporal manner. How such transcriptome-wide effects are orchestrated at
the molecular level remains an open question. Here we show that 30-untranslated regions
(30 UTRs) of multiple neural transcripts contain AU-rich cis-elements (AREs) recognized by
tristetraprolin (TTP/Zfp36), an RNA-binding protein previously implicated in regulation of
mRNA stability. We further demonstrate that the efﬁciency of ARE-dependent mRNA
degradation declines in the neural lineage because of a decrease in the TTP protein
expression mediated by the NS-enriched microRNA miR-9. Importantly, TTP downregulation
in this context is essential for proper neuronal differentiation. On the other hand, inactivation
of TTP in non-neuronal cells leads to dramatic upregulation of multiple NS-speciﬁc genes. We
conclude that the newly identiﬁed miR-9/TTP circuitry limits unscheduled accumulation
of neuronal mRNAs in non-neuronal cells and ensures coordinated upregulation of these
transcripts in neurons.
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E
ukaryotic gene expression is an intricate balancing
act between transcription and post-transcriptional steps
of RNA metabolism. Developmental readjustment of this
balance allows large cohorts of genes to be expressed in cell- and
tissue-speciﬁc manner. Among other regulators, RNA-binding
proteins (RBPs) provide an important means for modulating
RNA processing and turnover in the context of cellular
differentiation1–4. For example, downregulation of the
ubiquitously expressed RBP Ptbp1/PTB/hnRNAP I in the
developing brain stimulates neuron-speciﬁc alternative
pre-mRNA splicing patterns and stabilizes a subset of neuronal
transcripts5,6.
We have previously shown that Ptbp1 levels are dampened in
developing the nervous system (NS) by the microRNA miR-124, a
non-coding molecule base pairing with partially complementary
sites in the Ptbp1 mRNA7. Notably, Ptbp1 knockdown is
sufﬁcient to induce morphological and functional neuron-like
differentiation in non-neuronal cells8,9. Several important targets
have been described for another brain-enriched microRNA,
miR-9 (refs 10,11). However, it is unknown whether the
transcriptome-wide effects of miR-9 might be ampliﬁed through
post-transcriptional mechanisms similar to those implemented in
the miR-124/Ptbp1 circuitry.
In contrast to Ptbp1, many RBPs are enriched in the NS4,12. Of
these, the Hu/Elav-like (for example, HuB/Elavl2, HuC/Elavl3
and HuD/Elavl4) and Nova (for example, Nova1 and Nova2)
protein families are essential for proper brain development and
function13–15. NS-speciﬁc Hu/Elavl proteins stabilize important
neuronal mRNAs including that encoding the axonal Gap43
protein and additionally regulate several neuron-speciﬁc pre-
mRNA-processing reactions16,17. Besides their other functions,
Nova proteins control a large fraction of neuron-speciﬁc
alternative splicing events thus diversifying the proteome and
modulating steady-state levels of a subset of mRNAs18,19.
Mechanisms ensuring elevated expression of these RBPs in the
NS are poorly understood.
A considerable fraction of mammalian transcripts contains
30 untranslated region (30 UTR)-localized AU-rich cis-elements
(AREs)20,21. These sequences often diminish mRNA stability by
recruiting corresponding trans-acting RBPs22,23. Tristetraprolin
(TTP/Zfp36), a zinc-ﬁnger protein interacting with AUUUA
motifs typically within a longer AU-rich context (for example,
UAUUUAU), provides an important example of this RBP
category24. TTP/Zfp36 knockout (KO) mice develop severe
autoimmune/inﬂammatory phenotypes caused by elevated
expression of the tumour necrosis factor (TNF)-a mRNA
containing eight UAUUUAU motifs25,26.
In addition to TNF-a, TTP is known to destabilize other
mRNAs encoding a wide range of cytokines, growth factors and
proto-oncogenes24,27. Interestingly, TTP has been implicated in
the regulation of HuR/Elavl1, a ubiquitously expressed paralogue
of HuB, HuC and HuD28,29. A recent transcriptome-wide
crosslinking and immunoprecipitation survey has suggested that
TTP interacts with a substantially larger number of mRNAs30.
However, what biological processes might rely on this extended
repertoire of TTP targets remains unclear.
Here we report that 30 UTRs of many mRNAs encoding
important NS-enriched proteins including neuronal RBPs contain
TTP-speciﬁc UAUUUAU sequences. We show that activity of
the TTP/ARE pathway is diminished in developing NS at least in
part because of miR-9-mediated TTP downregulation. This in
turn licenses expression of the ARE-containing NS-enriched
transcripts. We further show that TTP downregulation is
necessary for proper neuronal differentiation in vitro and is
sufﬁcient for increased expression of UAUUUAU-containing
mRNAs in a transformed mouse cell line. Importantly, our
analyses of mouse embryonic ﬁbroblasts (MEFs) from wild-type
(WT) and TTP KO animals suggest that TTP dampens
steady-state levels of an extensive subset of neural mRNAs in
non-neural cells in vivo. These data implicate TTP as a novel
post-transcriptional repressor of NS-speciﬁc genes and uncover a
molecular mechanism alleviating this repression during brain
development.
Results
AU-enriched mRNAs tend to accumulate in the neural lineage.
We examined previously published microarray data31 and
detected a signiﬁcant over-representation of A- an U-rich
pentamers in predicted 30 UTRs32 of genes upregulated during
embryoid body/retinoic acid (EB/RA)-induced neural differen-
tiation of mouse P19 cells (Supplementary Fig. 1a). Interestingly,
the top hits included the three pentamers, UAUUU, UUUAU and
AUUUA (Supplementary Fig. 1a and Supplementary Data 1),
overlapping with the UAUUUAU motif known to function
as a tristetraprolin (TTP/Zfp36)-dependent ARE24. Moreover,
mRNAs containing one or several ARE cores, AUUUA21 were
more frequently upregulated in differentiated cultures compared
with their AUUUA-less counterparts and this effect was
especially pronounced for mRNAs with six or more AUUUA
pentamers (Supplementary Fig. 1b,c).
Neural differentiation involves dramatic changes in mRNA 30
UTR lengths triggered by globally altered patterns of pre-mRNA
cleavage and polyadenylation (APA)33–36. Since it is difﬁcult
to distinguish between APA isoforms using microarrays, we
analysed transcriptomes of undifferentiated and EB/RA-
differentiated P19 cells by the 30 Region Extraction And Deep
Sequencing (30 READS) procedure recently developed by our
group32. The newly acquired 30READS data showed a good
correlation with the microarray results (Pearson’s correlation
coefﬁcient r¼ 0.72, Po2 10–16; Supplementary Fig. 1d).
Importantly, 30 UTRs of 30READS-deduced transcripts up-
regulated in differentiated P19 cells often contained one or
several AUUUA motifs (Fig. 1a,b). Overall, these analyses
suggested that ARE-containing transcripts might undergo
coordinated upregulation during neural differentiation.
Many neural mRNAs are tristetraprolin targets. Important
examples of mRNAs upregulated in differentiated P19 cells on the
basis of the microarray and the 30 READS data contained two or
more UAUUUAU motifs in their 30 UTRs and encoded neuronal
markers (for example, Tubb3, Eno2 and Pcdh19), brain-enriched
RBPs (for example, HuB/Elavl2, HuC/Elavl3, HuD/Elavl4 and
Nova1) along with neurotrophic receptors and their ligands (for
example, Ntrk2 and Bdnf; Fig. 1c and Supplementary Fig. 2). In
most of these cases, UAUUUAU motif occurred within a longer
stretch of A/U nucleotides (Fig. 1c and Supplementary Fig. 2),
a characteristic feature of bona ﬁde AREs21,24. Our reverse
transcription–quantitative PCR (RT–qPCR) analyses with open
reading frame-speciﬁc primers conﬁrmed that these mRNAs were
indeed dramatically upregulated in EB/RA-differentiated P19
cells (Fig. 1c and Supplementary Fig. 2; Fu/Ru and F/R pairs,
respectively).
To account for differentiation-induced changes in APA
patterns, we re-analysed the above P19 samples using
RT–qPCR with primer pairs designed towards downstream
30 UTR sequences (Fig. 1c; Fd/Rd pairs). For genes with most
UAUUUAU sequences preceding a single constitutive cleavage/
polyadenylation site (pA; Tubb3) or several alternative pA’s
(Eno2 and HuB), upregulation effects detected using this
assay were largely similar to the above Fu/Ru RT–qPCR data
(Fig. 1c). However, when UAUUUAU repeats followed proximal
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alternative pA’s, Fd/Rd targets were upregulated to a signiﬁcantly
larger extent than Fu/Ru ones (HuR/Elavl1, Nova1 and Ntrk2;
Fig. 1c). Of note, the UAUUUAU motifs occurring in the
30-terminal extension of the long, brain-enriched APA isoform
of the HuR mRNA have been previously implicated in
TTP-dependent destabilization28,29,37.
Notably, when we analysed a subset of the above mRNAs
(Tubb3, HuB, HuC, HuD and Nova1) expressed in undiffer-
entiated P19 cells using ultraviolet crosslinking/immunoprecipi-
tation (CLIP) with TTP-speciﬁc antibodies, TTP–mRNA
interaction was detected for Tubb3, HuB, HuC and Nova1
(Fig. 2a,b). We could not obtain conclusive HuD-speciﬁc data
likely because of the extremely low expression of this mRNA in
undifferentiated P19 cells. As expected28, the anti-TTP antibody
generated a robust CLIP signal for the HuR mRNA control
(Fig. 2b). On the other hand, no signiﬁcant TTP binding was
detected for the Alas1 mRNA lacking UAUUUAU sequences
(Fig. 2b).
Overall, these data indicated that at least a fraction of
ARE-containing and TTP-interacting mRNAs was upregulated
during neuronal differentiation. Paradoxically, long alternatively
cleaved and polyadenylated isoforms containing a larger number
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Figure 1 | ARE-containing transcripts are frequently upregulated during neural differentiation. (a) Empirical cumulative distribution function (ECDF)
plots for 30READS-deduced expression changes in P19 cells undergoing neural differentiation. Individual curves correspond to groups of transcripts with
speciﬁed numbers of AUUUA motifs within the 30 UTR. (b) Comparison of the transcript groups in a using two-sided KS test suggests that mRNAs
containing one or several AUUUA motifs are more frequently upregulated than their AUUUA-less counterparts. (c) Changes in the expression levels of
ARE-containing mRNAs in P19 cells after 3.5 days of EB/RA-induced neural differentiation. Top, 30 UTR diagrams showing positions of pA sites, AREs and
primers used for RT–qPCR analyses. Long black ticks, canonical AAUAAA and AUUAAA pA hexamers occurring within 10–30 nt upstream of the 30 end in
at least one cDNA or EST clone (UCSC Genome Browser) or one-nucleotide modiﬁcations of these hexamers used as pA sites in at least ﬁve cDNA/EST
clones. Short black ticks, AAUAAA and AUUAAA pA hexamers not associated with available cDNA clones. Red ovals, UAUUUAU motifs occurring as a
part ofZ12 nt consecutive AU-nucleotide sequences with the number of individual UAUUUAU heptamers indicated inside the oval. Red ticks, UAUUUAU
motifs present within o12 nt AU sequences. Bottom, RT–qPCR relative expression data obtained for undifferentiated (Undif) P19 cultures and cultures
differentiated for 3.5 days using upstream (Fu/Ru) or downstream (Fd/Rd) primer pairs. Expression levels in the corresponding undifferentiated samples
are set to 1. Data are averaged from three experiments±s.d. and compared by t-test.
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of these motifs appeared to be upregulated to a greater extent
than their shorter variants with fewer UAUUUAUs.
The TTP pathway is inactivated during neural differentiation.
A parsimonious explanation for the above results would involve a
decrease in the efﬁciency of TTP/ARE-dependent RNA degra-
dation in differentiated P19 cells. To explore this possibility, we
generated two dTomato cassettes containing HuR 30 UTRs with
mutated pA2, a major pA utilized in proliferating cells28 (Fig. 2c).
One of these constructs (dTom-3’HuR-pA2mut) contained the
WT ARE repeat previously shown to be targeted by TTP28,
whereas the other one (dTom-30HuR-pA2mut/DARE) had this
element deleted (Fig. 2c). Both plasmid-encoded transcripts were
expected to terminate predominantly at the downstream pA4-
pA7 sites, thus generating long mRNA products with (dTom-
30HuR-pA2mut) or without AREs (dTom-30HuR-pA2mut/
DARE)28.
The two constructs were then used to generate corresponding
single-copy transgenic P19 cells using a previously described
procedure38. As expected, when we analysed dTomato expression
in these cells using ﬂow cytometry, undifferentiated dTom-
30HuR-pA2mut/DARE samples showed noticeably higher
dTomato levels than undifferentiated dTom-30HuR-pA2mut
cells (Fig. 2d; P¼ 4.7 10–203, Wilcoxon rank-sum test).
However, dTomato expression levels in the two transgenic
populations became virtually indistinguishable following EB/RA
differentiation (Fig. 2d; P¼ 0.060, Wilcoxon rank-sum test). We
also failed to detect any difference in dTomato expression
between neuron-like fractions of the two differentiated cultures
positive for neuronal tubulin bIII (TubbIII) marker, a product of
the Tubb3 gene mentioned above (Supplementary Fig. 3; P¼ 0.24,
Wilcoxon rank-sum test).
Since the above results suggested that the efﬁciency of
ARE-mediated RNA destabilization could be reduced during
neuronal differentiation, we introduced the above dTom-30HuR-
pA2mut and dTom-30HuR-pA2mut/DARE plasmids into pri-
mary cortical neurons from E15.5 mouse embryos using a
transient magnetofection protocol (Supplementary Fig. 4; see
Methods for details). Subsequent ﬂow cytometry analyses showed
that both neuronal populations expressed dTomato protein at
statistically indistinguishable levels (P¼ 0.76, Wilcoxon rank-sum
test). On the other hand, magnetically transfected primary
MEFs expressed signiﬁcantly larger amounts of dTomato from
dTom-30HuR-pA2mut/DARE than from dTom-30HuR-pA2mut
(Supplementary Fig. 4; P¼ 1.8 10–180, Wilcoxon rank-sum
test). We concluded that the UAUUUAU-dependent branch of
the RNA decay pathway was largely inactive in neurons.
TTP levels decrease as a result of miR-9 upregulation. To test
whether reduced efﬁciency of ARE-dependent mRNA decay in
developing neurons could be because of corresponding changes in
the TTP expression, we analysed P19 cells undergoing EB/RA
differentiation by immunoblotting with a TTP-speciﬁc antibody
(Fig. 3a). TTP protein levels progressively diminished as a
function of differentiation time (Fig. 3a). Immunoblot analysis
of mouse embryonic stem cells, neural stem cells and primary
cortical neurons further suggested that that protein levels
of both TTP and its closely related paralogue BRF1/Zfp36l1
were also dramatically reduced during neurogenesis in vivo
(Supplementary Fig. 5). Interestingly, TTP appeared to be
downregulated at an earlier developmental point than BRF1
(Supplementary Fig. 5). We noticed that the 30 UTR of
TTP–mRNA contained an evolutionarily conserved sequence
complimentary to the seed region of microRNA miR-9 (Fig. 3b)
known to be expressed in neuronal progenitors and neurons11.
As expected39, mature miR-9 levels increased markedly in
differentiating P19 cultures (Fig. 3c), thus suggesting a possible
mechanism for TTP downregulation.
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Figure 2 | Activity of the TTP/ARE pathway is reduced in cells undergoing neural differentiation. (a) CLIP assay diagram (see Methods for details).
(b) RT–qPCR analysis of mRNA ultraviolet-crosslinked and co-immunoprecipitated with a TTP-speciﬁc rabbit antibody from undifferentiated P19 cells.
Note that the anti-TTP antibody co-immunoprecipitates signiﬁcantly larger fractions of ARE-containing mRNA species (HuR, Tubb3, HuB, HuC and Nova1)
than corresponding unspeciﬁc rabbit IgG control (set to 1). On the other hand, no signiﬁcant difference between anti-TTP and the control is detected for the
Alas1 mRNA encoding aminolevulinic acid synthase 1 and containing no UAUUUAU motifs. Data are averaged from three experiments±s.d. and
normalized to background crosslinking signal from Gusb ‘housekeeping’ mRNA lacking UAUUUAU’s. (c) dTomato transgenes fused with PAS2-mutated
HuR 30 UTRs either containing the WT ARE (dTom-30HuR-pA2mut) or lacking this sequence (dTom-30HuR-pA2mut/DARE). (d) Expression levels of the
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plotted for reference.
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To assess whether miR-9 could directly target the predicted
site, we fused a Renilla luciferase (RLuc) reporter gene with the
TTP 30 UTR and co-transfected HEK293T cells with this
construct (RLuc-30TTP-wt) and either a miR-9 expression
plasmid or the corresponding empty vector (Fig. 3d,e).
Satisfyingly, miR-9 reduced RLuc expression B2.9-fold
(P¼ 4.7 10–5; t-test) and mutation of the putative miR-9
target site (RLuc-30TTP-mir9TSmut) rescued RLuc expression
(P¼ 5.5 10–5; t-test; Fig. 3e). A similar rescue effect was
observed when we treated HEK293T cells co-transfected with
RLuc-30TTP-wt and miR-9 expression plasmid with a target
protector oligonucleotide shielding the miR-9 target site in the
TTP 30 UTR (Supplementary Fig. 6a).
To ensure that naturally occurring miR-9 levels were sufﬁcient
for the regulation, we transfected differentiated P19 cells
with an miR-9-speciﬁc antisense 20-O-meRNA oligonucleotide
(Fig. 3f). As expected40, this reduced mature miR-9 levels as
compared with control-treated cells (Fig. 3f). Notably, miR-9
downregulation resulted in increased TTP protein levels (Fig. 3g).
TTP protein levels also noticeably increased in EB/RA-treated
P19 cells in response to TTP-speciﬁc miR-9 target site protector
(Supplementary Fig. 6b). We concluded that TTP expression is
reduced during neural differentiation and that this effect is at least
in part mediated by miR-9.
TTP downregulation is required for neuronal differentiation.
To determine whether TTP downregulation was required for
neuronal differentiation, we prepared P19 cells containing a
single-copy HA-tagged TTP transgene driven by a doxycycline
(Dox)-inducible promoter and lacking its natural 30 UTR
(TRE-TTP; Fig. 4a). Following the EB/RA induction, TTP
expression was induced by Dox and the cells were analysed
by RT–qPCR, immunoblotting and immunoﬂuorescence. The
RT–qPCR assay suggested that expression of the miR-9-resistant
TRE-TTP transgene in differentiated P19 cells led to a signiﬁcant
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induced neural differentiation. U6 RNA is used as a loading control. (d) RLuc-30TTP-wt and RLuc-30TTP-miR9TSmut Renilla luciferase reporter constructs
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U6 RNA as a loading control. (g) Immunoblot analysis showing that knockdown of miR-9 carried out as described in f leads to noticeable upregulation of
the TTP protein.
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downregulation of neuronal genes both containing and lacking
UAUUUAU repeats in their 30 UTRs (Fig. 4b and Supplementary
Fig. 7a). The immunoblot analysis conﬁrmed Dox-inducible
expression of transgenic TTP and showed that this lowered
protein levels of two TTP targets, HuB and TubbIII (Fig. 4c),
as well as neuronal marker Map2 not predicted to be targeted
by TTP (Supplementary Fig. 7b). We also detected a
signiﬁcant decrease in the number of TubbIII-positive cells in
EB/RA-differentiated P19 cultures expressing transgenic TTP
(Fig. 4d,e).
To address functional signiﬁcance of reduced TTP expression
during neuronal development in vivo, we transiently magneto-
fected primary cortical neurons from E15.5 embryos with a
plasmid expressing recombinant TTP from a constitutive
promoter (pBS-CMV-TTP; Supplementary Fig. 8a,b). Subsequent
RT–qPCR analyses showed that this treatment signiﬁcantly
reduced steady-state levels of UAUUUAU-containing neuronal
mRNAs (Tubb3 and HuB) while having no detectable effect
on neuronal mRNA lacking UAUUUAU motifs (Map2 and
L1cam; S8c-d). Taken together, these results suggested that TTP
downregulation in the context of neurogenesis was required for
establishing a proper neuronal gene expression programme.
TTP dampens neuronal mRNAs in neuroblastoma cells. To test
whether reduced TTP expression was sufﬁcient for upregulation
of ARE-containing neuronal mRNAs, we knocked down TTP
expression in an easy-to-transfect mouse neuroblastoma cell line,
Neuro2a, with a corresponding small interfering (si) RNA (siTTP;
Fig. 5a). Compared with cells treated with siControl, treatment
with siTTP led to signiﬁcant upregulation of predicted TTP
targets, Tubb3, HuB, HuC, HuD and Nova1, at the mRNA level
(Fig. 5a), as well as noticeable accumulation of the HuB and
TubbIII proteins (Fig. 5b). Consistent with these data, our IF
staining showed that cultures treated with siTTP contained a
signiﬁcantly larger fraction of TubbIII-positive cells than the
control-treated ones (Fig. 5c,d). Conversely, overexpression of
TRE-TTP in Dox-treated single-copy transgenic Neuro2a cells
resulted in a modest but signiﬁcant decrease in the basal
expression levels of Tubb3, HuB, HuC, HuD and Nova1 mRNAs
(Supplementary Fig. 9). Thus, TTP limits expression levels
of ARE-containing neuronal mRNAs in a transformed non-
neuronal cell line.
TTP KO reprogrammes embryonic ﬁbroblast transcriptome.
To ﬁnd out whether TTP could repress neural genes in primary
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non-neural cells, we turned to the TTP/Zfp36 KO mouse model26.
Gene expression patterns of MEFs from the KO (TTP / )
animals and their WT (TTPþ /þ ) littermates have been
previously compared using a microarray approach41. The
authors treated ﬁrst-starved-then-serum-stimulated cells
expressing TTP at an elevated level with RNA polymerase
inhibitor actinomycin D and focused on a subset of transcripts
with increased half-lives in the KO cells as compared with the
WT. This resulted in identiﬁcation of 33 TTP targets representing
a range of functional categories41.
Since the bioinformatics pipeline used in this study could not
detect transcripts destabilized by TTP to undetectably low steady-
state levels in the WT background but rescued in the KO, we re-
analysed the data focusing on genes consistently showing
signiﬁcant expression differences between corresponding KO
and WT samples. This yielded 80 genes represented by 100
distinct probes sets that were signiﬁcantly upregulated and 95
genes represented by 131 probes set that were downregulated
across all KO samples (410-fold effects; Benjamini–Hochberg-
corrected Po0.05). Strikingly, the upregulated set was signiﬁ-
cantly enriched for neuron-speciﬁc Gene Ontology processes
(Supplementary Data 2) and contained Tubb3 and HuB along
with several other NS-enriched transcripts (Supplementary
Data 3). The upregulated genes tended to be expressed at a level
noticeably lower than the transcriptome median in the WT while
reaching the median in the KO cells (Supplementary Fig. 10a).
To test whether inactivation of TTP/Zfp36 might shift the
transcriptome of MEF cells towards that of the NS, we utilized
the previously described tissue-speciﬁc expression ranking
approach42. Probe sets were ﬁrst ranked according to their
expression levels in the cerebral cortex using an Affymetrix gene
expression atlas available for 81 experimentally naive mouse
tissues and cell types. The ranks corresponded to position of the
cerebral cortex in the list of tissues/cells arranged in an increasing
expression order such that genes expressed in cerebral cortex
lower than anywhere else were assigned rank 1 and genes
expressed higher than anywhere else were ranked 81.
Notably, cerebral cortex rank distribution plotted for
upregulated genes was noticeably shifted towards high-ranking
genes as compared with the whole array (Fig. 6a and
Supplementary Fig. 10b; P¼ 4.23 10–9; one-sided Kolmo-
gorov–Smirnov (KS) test). On the other hand, downregulated
genes were statistically indistinguishable from the whole array
(Fig. 6a and Supplementary Fig. 10b; P¼ 0.976; one-sided KS
test). When we repeated this procedure for the rest of the tissues/
cell types represented in the atlas, all NS-speciﬁc distributions
showed signiﬁcant right shifts for genes upregulated in KO MEFs
(Fig. 6b and Supplementary Fig. 10c). NS-speciﬁc P values
were signiﬁcantly lower than their non-NS counterparts for
upregulated (inset in Fig. 6b) but not downregulated genes
(Supplementary Fig. 10d). A similar trend was apparent when we
analysed changes in the NS and non-NS rank medians
(Supplementary Fig. 10e). Taken together, these analyses
suggested that TTP repressed a large cohort of neural transcripts
in stimulated MEFs.
To examine whether basal TTP expression levels could dampen
expression of neural transcripts in non-stimulated ﬁbroblasts,
we propagated the WT and KO MEFs kindly provided by the
Blackshear laboratory in the presence of 10% of fetal bovine
serum (FBS) for several days and analysed the microarray hits
using RT–qPCR and immunoblotting. Both Tubb3 and HuB
mRNAs were dramatically upregulated in the KO ﬁbroblasts
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(Fig. 6c) and this effect was also apparent at the protein level
(Fig. 6e). Similar upregulation was detected for 10 additional
microarray hits with documented NS functions (Supplementary
Fig. 11a,b) including Gap43 and Gria3 mRNAs lacking
30-terminal UAUUUAU motifs but known to be stabilized by
Hu/Elavl and Nova proteins, respectively19,43,44.
Although HuC, HuD and Nova1 were not shortlisted with our
microarray analysis algorithm, RT–qPCR quantitation showed
that these UAUUUAU-containing genes were also signiﬁcantly
upregulated in non-stimulated KO MEFs (Fig. 6c). TTP KO
MEFs also expressed increased amounts of the long alternatively
cleaved/polyadenylated isoform of the HuR mRNA (Fig. 6d). On
the other hand, TTP KO had no effect on the expression levels on
the Alas1 ‘housekeeping’ mRNA lacking UAUUUAU motifs
(Supplementary Fig. 11c). We concluded that one of the
TTP functions in non-neural cells in vivo could be dampening
steady-state expression of multiple neural transcripts.
Discussion
Our study suggests that, in addition to its well-documented role
in destabilizing mRNAs encoding cytokines, growth factors
and proto-oncogenes, TTP limits steady-state abundance of a
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Figure 6 | Extensive neural reprogramming of the transcriptome in TTP-KO embryonic ﬁbroblasts. (a) Distributions of cerebral cortex ranks for all
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considerable number of ARE-containing neuronal mRNAs in
non-neuronal cells (Fig. 7). These transcripts are upregulated in
cells undergoing neural differentiation since TTP protein
expression is diminished in this context by the brain-enriched
microRNA miR-9 (Fig. 7). The experiments with transgenic
P19 cells and primary neurons suggest that the newly identiﬁed
post-transcriptional circuitry is essential for proper neuronal
differentiation (Fig. 4 and Supplementary Fig. 8). Further
underscoring importance of this mechanism, the newly identiﬁed
TTP targets include mRNAs encoding RBPs from the Hu/Elavl
and Nova families known for their critical contributions to NS
development and function as well as mRNAs of essential
neuronal markers (for example, TubbIII)13–15,45.
Data presented in this study (for example, Figs 1c and 6d)
further indicate that reduced expression of TTP during neural
differentiation may enable expression of 30-elongated mRNA
APA isoforms appearing as a result of frequent skipping of open
reading frame-proximal alternative pA sites in the NS33–35. Given
the major role of the 30 UTR in deﬁning mRNA translational
efﬁciency, stability and intracellular localization, the impact of the
TTP dynamics on the cellular repertoire of APA isoforms
warrants further systematic investigation.
The newly identiﬁed regulation circuitry is evocative of the
previously described miR-124/Ptbp1 switch regulating the
choice between non-neuronal and neuronal splicing and mRNA
stability patterns7. In both cases, a post-transcriptional repressor
of neuronal genes is placed under a negative control of a
NS-enriched microRNA. This underscores the role of post-
transcriptional regulation in differentiating cells and suggests that
gene expression changes in this context rely on an extensive
crosstalk between microRNA- and RBP-mediated pathways.
Interestingly, another well-described example of such double
negative regulation logic is provided by the REST/NRSF complex,
a transcriptional repressor of neuronal genes in non-neuronal cell
that is inactivated in neurons through several molecular
mechanisms including the microRNA pathway10,46,47.
Earlier studies have demonstrated that miR-9 and miR-124
might stimulate neurogenesis in a synergistic manner. Indeed,
combined expression of these two microRNAs promoted
neuronal fate in differentiating mouse ES cell cultures48 and
triggered detectable trans-differentiation of embryonic ﬁbroblasts
into neurons49. By identifying a global repressor of neuronal
mRNA stability as one of the miR-9 targets, our work sheds new
light on molecular mechanisms underlying pro-neural activity of
this microRNA in mammals.
Although TTP is a critical component of the ARE-dependent
mRNA-destabilization machinery, several other RBPs controlling
mRNA stability and translation also interact with AREs22. Some
of these proteins, including TTP paralogues BRF1/Zfp36l1 and
BRF2/Zfp36l2, are thought to interact with TTP-speciﬁc AREs24.
Although BRF2 protein was undetectable in cells undergoing
neurogenesis, BRF1 was expressed at readily detectable levels
early in neurogenesis and dramatically downregulated in neurons
(Supplementary Fig. 5). Therefore, it might be interesting—as one
of the future directions—to examine possible contribution of
BRF1 to post-transcriptional regulation of neural genes.
Yet another line of further studies should focus on the
Hu/Elavl protein functions. All four genes encoding mammalian
Hu/Elavl paralogues contain 30-termianal AREs (Fig. 1c and
Supplementary Fig. 2) and the steady-state levels of HuB, HuC
and HuC, increase markedly on TTP downregulation (Figs 5
and 6). Importantly, Hu proteins are known to interact with
U-rich sequences that include but are not limited to AREs
recognized by TTP and its paralogues14,30,50. This interaction
often stabilizes mRNA targets possibly by minimizing their
interaction with repressive RBPs51,52. Therefore, even partial
stabilization of the HuB, HuC and HuD mRNAs triggered by
reduced TTP expression may initiate a positive reinforcement
mechanism further increasing stability of ARE-containing
mRNAs in a Hu/Elavl-dependent manner.
Hu/Elavl protein accumulation would potentially explain the
robust upregulation of the Gap43 mRNA in the TTP KO MEFs
(Supplementary Fig. 11b) Indeed, this important mRNA is known
to be stabilized in neurons through a 30 UTR U-rich cis-element
distinct from a TTP-speciﬁc ARE but capable of recruiting
HuD43,44. Similarly, initial upregulation of Nova1 protein might
account19 for the increase in the steady-state level of the Gria3
mRNA lacking discernible AREs (Supplementary Fig. 11b and
Supplementary Data 3).
Intriguingly, human Hu/Elavl and Nova have been originally
identiﬁed as auto-antigens associated with paraneoplastic neuro-
logical disorders and members of these protein families are
consistently overexpressed in several types of cancers53.
Moreover, elevated expression of the neural enolase subunit
encoded by the Eno2 gene (Fig. 1c) is commonly used as a
neuroendocrine tumour biomarker54. Since human orthologues
of mouse HuB, HuC, HuD, Nova1 and Eno2 genes contain readily
discernable AREs and TTP is often downregulated in
tumours27,55,56, it will be interesting to examine whether
ectopic expression of HuB/C/D, Nova1 and other NS-speciﬁc
antigens in cancer cells might be triggered by aberrantly low TTP
levels. Notably, TTP knockdown was sufﬁcient for HuB/C/D and
Nova1 upregulation in Neuro2a neuroblastoma cells (Fig. 5).
In conclusion, our work uncovers a post-transcriptional
circuitry dampening expression of multiple neuronal genes in
non-neuronal cells and allowing their coordinated upregulation
in neurons. This ﬁnding may open up new possibilities for
improved conversion of non-neuronal cells into neurons for
research and therapeutic applications and inform further studies
of mechanisms driving overexpression of onconeural antigens by
tumour cells.
Methods
Plasmids. Mouse TTP-HA expression plasmid (pBS-CMV-TTP) was a gift
from Perry Blackshear and pBS-vector control (pBluscriptR) was from RIKEN
BioResource Center. New constructs were generated using standard molecular
cloning techniques57 as outlined in Supplementary Data 4. Site-speciﬁc mutations
were introduced using modiﬁed QuikChange site-directed mutagenesis protocol
(Stratagene) using corresponding mutagenic primers (Supplementary Data 5) and
KAPA HiFi DNA polymerase (KAPA Biosystems). All primers used in this study
are listed in Supplementary Data 5 and plasmid maps and sequences are available
on request.
Cell lines. P19 cells (ATCC) were routinely propagated in P19 growth medium
(P19GM) containing a-MEM (Hyclone), 10% FBS (Hyclone, characterized grade),
100 IUml 1 penicillin and 100 mgml 1 streptomycin (Life Technologies).
HEK293T and Neuro2a cells (ATCC) were cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM; Hyclone) containing 10% FBS, 100 IUml 1 penicillin and
100 mgml 1 streptomycin (Life Technologies). The cells were maintained in a
humidiﬁed incubator at 37 C and 5% CO2.
Mouse TTP was knocked down in cell lines using corresponding
ON-TARGETplus mixture containing four proprietary siRNAs designed by
Dharmacon/Thermo Scientiﬁc. Non-targeting control ON-TARGETplus siRNA
was also from Dharmacon/Thermo Scientiﬁc. miR-9 was inactivated using either
an anti-miR-9 antisense 20OMe-RNA oligonucleotide (50-UCAUACAGCUAGAU
AACCAAAGA-30 ; Dharmacon/Thermo Scientiﬁc) or a target protector (Qiagen)
against the predicted miR-9-binding sequence within mouse TTP 30 UTR (50-CCC
UCCUAAAGCAAAUAGCCAAAGCCAUUG-30). Transfections were carried out
using Lipofectamine 2,000 (Life Technologies) as recommended. To transfect cells
cultured in a 60-mm dish (4ml medium), we typically combined 200–500 pmol
of an appropriate siRNA or an oligonucleotide with 10 ml of Lipofectamine
2000 pre-diluted with 250 ml of Opti-MEM I reduced serum medium (Life
Technologies).
EB/RA differentiation of P19 cells. To initiate neural differentiation7, P19 cells
were plated at 1 105ml 1 into bacterial-grade dishes in P19 induction medium
(P19IM) containing a-MEM (Hyclone), 5% FBS (Hyclone, characterized grade)
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and 1 mM of all-trans-RA (Sigma). Two days post plating, P19IM was replaced and
the EBs were cultured for another 2 days. The EBs harvested from a single 10 cm
dish were washed with 1 PBS and dissociated in 2ml of 0.25% trypsin–EDTA
(Life Technologies) supplemented with 100 mgml 1 DNase I (Roche) for 10min
at 37 C. The cell suspensions were passed through 100-mm strainers
(BD Biosciences) and plated into poly-D-lysine (Sigma)-treated dishes in
P19IM lacking RA. Twelve hours after plating, the medium was changed to
Neurobasal (Life Technologies) additionally containing 1 N-2 supplement
(Life Technologies) and 2mM GlutaMAX (Life Technologies) and the cells were
allowed to undergo neural differentiation for up to six more days.
Primary cells. Mouse embryonic neural stem cells were isolated from E14 cortices
using NeuroCult Proliferation Kit Mouse (STEMCELL Technologies) and
maintained as recommended. Primary neurons were prepared from E15.5 mouse
cortices and cultured essentially as in ref. 58, except no astroglial feeders were used
for cultures maintained r7 days in vitro (DIV). Neurons were transfected using
NeuroMag reagent (Oz Biosciences) as recommended. Brieﬂy, 2.4 106 cortical
neurons were plated per 60-mm dish (Corning) pretreated with poly-D-lysine
(Sigma). At DIV2–DIV5, 0.1 mg of TTP expression plasmid (pBS-CMV-TTP) or
corresponding vector control or 4 mg of a dTomato reporter plasmid (dTom-
30HuR-pA2mut or dTom-30HuR-pA2mut/DARE) was incubated with 6 ml
NeuroMag beads in 150 ml Opti-MEM I for 20min and the mixture was added
dropwise to the dish containing neurons. The cultures were then incubated on
top of Super Magnetic Plate (Oz Biosciences) for 40min and incubated for another
40–48 h at 37 C and 5% CO2 before subsequent analyses.
Flow cytometry. We used natural dTomato ﬂuorescence to sort transgenic P19
cultures and transiently transfected neurons and MEFs. For intracellular staining,
cells were trypsinized, washed and ﬁxed at 2 105 cells per ml in 1 PBS
containing 2% paraformaldehyde for 15min at room temperature. Fixed cells were
washed twice with 1PBS additionally containing 1% BSA. This was followed
by incubation with blocking/permeabilization buffer (1PBS, 10% horse serum,
1% BSA and 0.15% saponin) for 1 h at room temperature. The cells were then
incubated with an anti-Tubb3 (Tuj1) primary antibody diluted in blocking/
permeabilization buffer at 4 C for 1 h. Cells were washed twice with 1 PBS
additionally containing 1% BSA and 0.15% saponin and incubated with a
corresponding Alexa-488-conjugated secondary antibody (Life Technologies)
diluted 1:1,000 in blocking/permeabilization buffer for 45min at 4 C. Cells were
ﬁnally washed twice with 1 PBS additionally containing 1% BSA and 0.15%
saponin and were analysed using a FACSCalibur ﬂow cytometer (BD).
Routine molecular biology procedures. Isolation of total RNA, mRNA northern
blot analysis, RT–qPCR, immunoblotting, immunoﬂuorescence and luciferase
assays were carried out using standard protocols28. MicroRNA northern blot
analysis59 was carried out using an appropriate 50-[32P]-labelled antisense DNA
oligonucleotide probes (Supplementary Data 5). RT–qPCR signals obtained using
gene-speciﬁc primers were normalized to either glyceraldehyde-3-phosphate
dehydrogenase or b-glucuronidase housekeeping mRNA controls (Supplementary
Data 5; http://www.qiagen.com/spotlight-pages/newsletters-and-magazines/
articles/endogenous-controls/). In luciferase reporter assays (Dual-Glo, Promega),
Renilla reniformis luciferase activity was normalized to that of Photinus pyralis
ﬁreﬂy luciferase expressed from the pEM231 plasmid7. The following antibodies
were used for immunoblotting, immunoﬂuorescence, intracellular staining and
CLIP: mouse monoclonal anti-b-tubulin (Life Technologies), rabbit polyclonal
anti-HA tag (Zymed/Life Technologies), mouse monoclonal anti-Tubb3 (Tuj1;
Covance), rabbit polyclonal anti-Map2 (Covance), rabbit polyclonal anti-HuB
(Millipore), rabbit polyclonal anti-TTP (a gift from Dr. Blackshear, NIH) and
rabbit polyclonal anti-BRF1/BRF2 (Life Technologies). Transgene integration using
high-efﬁciency low-background recombination-mediated cassette exchange38.
Brieﬂy, P19 acceptor cell line P19-A9 (ref. 38) was co-transfected with a 99:1
mixture of transgene-encoding plasmid and the nlCre expression plasmid
(pEM784) and recombinant cells were selected using puromycin.
RNA-protein CLIP. We investigated TTP–RNA interactions using CLIP protocol
modiﬁed from ref. 28. Brieﬂy, 107 P19 cells were ultraviolet-crosslinked at 254 nm,
0.4 J cm 2 and lysed with the Lysis buffer (50mM HEPES (pH 7.0), 60mM KCl,
5mM MgCl2 and 0.5% NP-40, 1mM dithiothreitol, 0.1 unit per ml rRNasin). The
extracts were pre-cleared by incubation with Dynabeads Protein G (Life
Technologies) for 2 h at 4 C and incubated with rabbit anti-TTP antibody or a
nonspeciﬁc rabbit IgG control at 4 C overnight. The antigen–antibody complexes
were incubated with Dynabeads Protein G for 2 h at 4 C with constant agitation.
The beads were then washed with the Lysis buffer and incubated with the Lysis
buffer additionally containing 0.1% SDS and 0.5mgml 1 proteinase K (Ferments)
at 50 C for 30min to recover the RNAs from the crosslinked complexes. RNAs
were extracted with phenol–chloroform, precipitated with ethanol and assayed
using RT–qPCR.
RNA sequencing. Total RNAs were extracted from undifferentiated and 3.5-day
differentiated P19 cells with Trizol (Life Technologies) as recommended and used to
prepare 30READS cDNA libraries32. RNA sequencing was carried out using a HiSeq
2500 machine (Illumina). Reads were mapped to the mouse genome (mm9) using
Bowtie2 (local mode) and those with mapping quality score Z10 were selected for
further analyses. Reads with two or more non-genomic A’s following the genome-
encoded part were qualiﬁed as polyadenylation site-supporting (PASS). All PASS
reads mapping to the 30 UTRs were used to calculate corresponding gene expression
levels represented as reads per million of total PASS reads. The log2-based reads per
million ratios between 3.5-day differentiated and undifferentiated samples were used
to assess neural differentiation-induced changes in gene expression levels.
Data analyses. Statistical analyses were performed using Excel and R (http://
www.R-project.org/). Images were quantiﬁed in ImageJ (http://imagej.nih.gov/ij/).
Unless indicated otherwise, data sets were compared using two-tailed t-test
assuming unequal variance. Published microarray comparison of gene expression
in undifferentiated and EB/RA-differentiated neuron-like P19 cells (7 days post
EB/RA induction) was downloaded from GEO (accession number GSE23710;
(ref. 31)). To analyse motif enrichment in this data set, we used 30-extended RefSeq
gene models assembled as previously described32. Enriched motifs were identiﬁed
using our previously published computer programme PROBE60. Differentiation-
induced expression changes in gene populations containing speciﬁed numbers
of AUUUA motifs were compared using two-sided KS test. Flow cytometry
data were analysed using the ﬂowCore Bioconductor package (http://www.
bioconductor.org/). MicroRNA target sites were predicted using Microcosm
Targets resource (http://www.ebi.ac.uk/enright-srv/microcosm/cgi-bin/targets/v5/
search.pl). Genes showing consistent expression changes in TTP KO MEFs
compared with the corresponding WT littermate controls were identiﬁed by
re-analysing previously published Affymetrix microarray results ((ref. 41); GEO
accession number GSE5324) using gcrma, geneﬁlter and limma Bioconductor
packages. Tissue and cell type-speciﬁc gene ranks42 were computed using the 81
experimentally naive samples from a published gcrma-normalized Affymetrix gene
expression atlas ((ref. 61); GEO accession number GSE10246).
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